Wilson Sonsini Goodrich & Rosati advised Goldman Sachs Alternatives on patent matters related to the transaction. Triveni Bio, a biotech company, announced the completion of a...
Triveni Bio’s $115 Million Series B Funding Round
Azurity Pharmaceuticals’ Acquisition of Slayback Pharma
White & Case and Wilson Sonsini Goodrich & Rosati advised Azurity Pharmaceuticals, Inc., and Kirkland & Ellis advised Slayback Pharma LLC on the transaction. Azurity Pharmaceuticals,...